About half of Americans "strongly" or "somewhat" favor having Medicare and Medicaid cover weight-loss drugs for people who have obesity, a recent AP-NORC poll showed, with about 2 in 10 opposed the idea and about one-quarter with a neutral view
Tirzepatide: The Dual Agonist Tirzepatide activates two hormone receptors: GLP-1 (glucagon-like peptide-1): Slows digestion, reduces appetite, and helps control blood sugar GIP (glucose-dependent insulinotropic polypeptide): Enhances insulin release and improves how your body processes fat Tirzepatide is FDA-approved and available today as Zepbound (for weight loss and sleep apnea) and Mounjaro (for type 2 diabetes)
Plasma protein binding, off-rate kinetics from albumin, and tissue distribution have all been examined in published characterization work (Coskun et al., 2022)
Resmetirom is generally well tolerated
Following protein precipitation, the samples were reconstituted in 100 mM TEAB with 8 M urea (pH 8.0), and subsequently diluted with eight volumes of 100 mM TEAB to reduce the urea concentration below 1 M
